Lotus Health Group Company (SHA:600186)
6.33
-0.20 (-3.06%)
Apr 24, 2025, 2:45 PM CST
SHA:600186 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 2,659 | 2,099 | 1,687 | 1,810 | 1,643 | Upgrade
|
Other Revenue | - | 2.07 | 4.02 | 5.23 | 11.82 | Upgrade
|
Revenue | 2,659 | 2,101 | 1,691 | 1,815 | 1,655 | Upgrade
|
Revenue Growth (YoY) | 26.55% | 24.23% | -6.83% | 9.69% | -2.81% | Upgrade
|
Cost of Revenue | 2,373 | 1,741 | 1,454 | 1,592 | 1,366 | Upgrade
|
Gross Profit | 285.54 | 359.71 | 237.42 | 223 | 288.96 | Upgrade
|
Selling, General & Admin | - | 180.87 | 131.72 | 128.47 | 150.91 | Upgrade
|
Research & Development | - | 28.73 | 21.56 | 22.07 | 17.72 | Upgrade
|
Other Operating Expenses | - | 9.85 | 10.2 | 9.63 | 8.65 | Upgrade
|
Operating Expenses | - | 225.27 | 167 | 157.4 | 175.78 | Upgrade
|
Operating Income | 285.54 | 134.45 | 70.41 | 65.6 | 113.17 | Upgrade
|
Interest Expense | - | -0.56 | -5.09 | -19.43 | -21.8 | Upgrade
|
Interest & Investment Income | - | 21 | 16.72 | 11.46 | 5.79 | Upgrade
|
Earnings From Equity Investments | - | 0.05 | -0.96 | - | - | Upgrade
|
Currency Exchange Gain (Loss) | - | 1.5 | 4.68 | -1.33 | -2.41 | Upgrade
|
Other Non Operating Income (Expenses) | -0.67 | -1.62 | -4.07 | 4.08 | 2.08 | Upgrade
|
EBT Excluding Unusual Items | 284.88 | 154.81 | 81.7 | 60.38 | 96.84 | Upgrade
|
Merger & Restructuring Charges | - | - | - | -0.18 | -1.04 | Upgrade
|
Gain (Loss) on Sale of Investments | - | - | - | -0.01 | - | Upgrade
|
Gain (Loss) on Sale of Assets | - | - | - | -3 | 0.05 | Upgrade
|
Asset Writedown | - | -1.43 | -0.96 | -3.29 | - | Upgrade
|
Other Unusual Items | - | 17.41 | -20.35 | -0.2 | 8.23 | Upgrade
|
Pretax Income | 284.88 | 170.8 | 60.39 | 53.7 | 104.08 | Upgrade
|
Income Tax Expense | 78.13 | 40.12 | 13.39 | 10.77 | 27.14 | Upgrade
|
Earnings From Continuing Operations | 206.74 | 130.68 | 47 | 42.93 | 76.94 | Upgrade
|
Minority Interest in Earnings | - | -0.75 | -0.81 | 1.43 | -2.66 | Upgrade
|
Net Income | 206.74 | 129.93 | 46.19 | 44.36 | 74.29 | Upgrade
|
Net Income to Common | 206.74 | 129.93 | 46.19 | 44.36 | 74.29 | Upgrade
|
Net Income Growth | 59.12% | 181.26% | 4.13% | -40.28% | 7.30% | Upgrade
|
Shares Outstanding (Basic) | 1,723 | 1,856 | 1,540 | 1,479 | 1,486 | Upgrade
|
Shares Outstanding (Diluted) | 1,723 | 1,856 | 1,540 | 1,479 | 1,486 | Upgrade
|
Shares Change (YoY) | -7.18% | 20.54% | 4.13% | -0.46% | 7.30% | Upgrade
|
EPS (Basic) | 0.12 | 0.07 | 0.03 | 0.03 | 0.05 | Upgrade
|
EPS (Diluted) | 0.12 | 0.07 | 0.03 | 0.03 | 0.05 | Upgrade
|
EPS Growth | 71.43% | 133.33% | - | -40.00% | - | Upgrade
|
Free Cash Flow | - | -36.13 | 13.4 | -31.46 | -884.41 | Upgrade
|
Free Cash Flow Per Share | - | -0.02 | 0.01 | -0.02 | -0.59 | Upgrade
|
Gross Margin | 10.74% | 17.12% | 14.04% | 12.29% | 17.46% | Upgrade
|
Operating Margin | 10.74% | 6.40% | 4.16% | 3.61% | 6.84% | Upgrade
|
Profit Margin | 7.78% | 6.19% | 2.73% | 2.44% | 4.49% | Upgrade
|
Free Cash Flow Margin | - | -1.72% | 0.79% | -1.73% | -53.45% | Upgrade
|
EBITDA | 302.63 | 151.53 | 87.91 | 76.94 | 124.59 | Upgrade
|
EBITDA Margin | 11.38% | 7.21% | 5.20% | 4.24% | 7.53% | Upgrade
|
D&A For EBITDA | 17.09 | 17.09 | 17.49 | 11.34 | 11.42 | Upgrade
|
EBIT | 285.54 | 134.45 | 70.41 | 65.6 | 113.17 | Upgrade
|
EBIT Margin | 10.74% | 6.40% | 4.16% | 3.61% | 6.84% | Upgrade
|
Effective Tax Rate | 27.43% | 23.49% | 22.17% | 20.05% | 26.08% | Upgrade
|
Revenue as Reported | - | 2,101 | 1,691 | 1,815 | 1,655 | Upgrade
|
Advertising Expenses | - | 4.42 | 0.77 | 1.27 | 0.9 | Upgrade
|
Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.